ES2249483T3 - Agonistas selectivos del receptor de glucocorticoides. - Google Patents

Agonistas selectivos del receptor de glucocorticoides.

Info

Publication number
ES2249483T3
ES2249483T3 ES01978673T ES01978673T ES2249483T3 ES 2249483 T3 ES2249483 T3 ES 2249483T3 ES 01978673 T ES01978673 T ES 01978673T ES 01978673 T ES01978673 T ES 01978673T ES 2249483 T3 ES2249483 T3 ES 2249483T3
Authority
ES
Spain
Prior art keywords
compound
formula
compound according
cells
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01978673T
Other languages
English (en)
Spanish (es)
Inventor
Stephen Alexander Barr
Michael Anthony Mckervey
Hughes Jean-Pierre Miel
David William Uni. of Manchester RAY
Andrew Michael University of Manchester BRASS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manchester
Original Assignee
University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0026947A external-priority patent/GB0026947D0/en
Priority claimed from GB0115161A external-priority patent/GB0115161D0/en
Application filed by University of Manchester filed Critical University of Manchester
Application granted granted Critical
Publication of ES2249483T3 publication Critical patent/ES2249483T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES01978673T 2000-11-03 2001-11-02 Agonistas selectivos del receptor de glucocorticoides. Expired - Lifetime ES2249483T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0026947 2000-11-03
GB0026947A GB0026947D0 (en) 2000-11-03 2000-11-03 Selective glucocorticoid receptor agonists
GB0115161 2001-06-20
GB0115161A GB0115161D0 (en) 2001-06-20 2001-06-20 Selective glucocorticoid receptor agonists

Publications (1)

Publication Number Publication Date
ES2249483T3 true ES2249483T3 (es) 2006-04-01

Family

ID=26245236

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01978673T Expired - Lifetime ES2249483T3 (es) 2000-11-03 2001-11-02 Agonistas selectivos del receptor de glucocorticoides.

Country Status (11)

Country Link
US (2) US20040102425A1 (de)
EP (1) EP1335928B1 (de)
AT (1) ATE303398T1 (de)
AU (2) AU1076802A (de)
CA (1) CA2427569C (de)
DE (1) DE60113145T2 (de)
DK (1) DK1335928T3 (de)
ES (1) ES2249483T3 (de)
NZ (1) NZ526216A (de)
PT (1) PT1335928E (de)
WO (1) WO2002036606A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070745A2 (en) 2002-02-20 2003-08-28 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids
US20050009798A1 (en) 2002-02-20 2005-01-13 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
EP1375517A1 (de) * 2002-06-21 2004-01-02 Smithkline Beecham Corporation Struktur der Ligandenbindedomäne des Glucocorticoidrezeptors umfassend eine expandierte Bindetasche und Anwendungsverfahren
JP2011507878A (ja) * 2007-12-21 2011-03-10 シェーリング コーポレイション Ｃ２０−ｃ２１置換グルココルチコイド受容体アゴニスト
WO2011087946A1 (en) * 2010-01-15 2011-07-21 Rigel Pharmaceuticals, Inc. Screening assay employing dex and gdf8
GB201320091D0 (en) * 2013-11-14 2014-01-01 Univ Manchester Selective glucocorticoid receptor ligands
CN116023425B (zh) * 2023-03-28 2023-06-20 南京师范大学 曲安西龙衍生物及其医药用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7502252A (nl) 1974-02-27 1975-08-29 Pierrel Spa Werkwijze voor het bereiden van een geneesmid- del met anti-inflammatoire werking, gevormd ge- neesmiddel verkregen volgens deze werkwijze alsmede werkwijze voor het bereiden van in het geneesmiddel gebruikte nieuwe steroiden.
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
US6024957A (en) 1993-06-02 2000-02-15 Research Corporation Technologies, Inc. Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
US5965434A (en) 1994-12-29 1999-10-12 Wolff; Jon A. Amphipathic PH sensitive compounds and delivery systems for delivering biologically active compounds
US5767113A (en) * 1995-05-10 1998-06-16 The Salk Institute For Biological Studies Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance
US5981517A (en) * 1996-05-09 1999-11-09 Soft Drugs, Inc. Androstene derivatives
EP1208847B8 (de) 1996-07-30 2007-02-14 Novartis AG Pharmazeutische zusammensetzungen zur behandlung der transplantatabstossung sowie der autoimmun- oder entzündlichen zustände
US6235891B1 (en) * 1999-03-31 2001-05-22 South Alabama Medical Science Foundation Glucocorticoid receptor agonist and decreased PP5
US6753329B2 (en) 2001-12-03 2004-06-22 Gpc Biotech Inc. Inhibitors of cyclin-dependent kinases, compositions and uses related thereto

Also Published As

Publication number Publication date
EP1335928A1 (de) 2003-08-20
WO2002036606A1 (en) 2002-05-10
ATE303398T1 (de) 2005-09-15
CA2427569A1 (en) 2002-05-10
DK1335928T3 (da) 2006-01-02
DE60113145T2 (de) 2006-06-22
EP1335928B1 (de) 2005-08-31
DE60113145D1 (de) 2005-10-06
AU2002210768B2 (en) 2008-01-10
US20040102425A1 (en) 2004-05-27
PT1335928E (pt) 2005-11-30
US7763596B2 (en) 2010-07-27
US20080090792A1 (en) 2008-04-17
NZ526216A (en) 2005-02-25
AU1076802A (en) 2002-05-15
CA2427569C (en) 2010-07-27

Similar Documents

Publication Publication Date Title
US6645955B1 (en) 3,6-dihydroxy-24-amidyl steroid derivatives
Belvisi et al. New glucocorticosteroids with an improved therapeutic ratio?
US7763596B2 (en) Selective glucocorticoid receptor agonists
TWI284646B (en) Novel anti-inflammatory androstane derivatives
US5866603A (en) Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
Bledsoe et al. Structure and function of the glucocorticoid receptor ligand binding domain
ES2821888T3 (es) Antagonistas del receptor CB1
AU2657292A (en) Novel gabaa receptor with steroid binding sites
US20140288035A1 (en) 18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17b-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosis
US20060025393A1 (en) Steroid derivatives
JP2003519624A (ja) 置換サポゲニン及びそれらの使用
ES2751457T3 (es) Glucocorticoides altamente potentes
JPH03504498A (ja) 芳香族ステロイド５‐α‐レダクターゼ抑制剤
Coghlan et al. The pursuit of differentiated ligands for the glucocorticoid receptor
US5801165A (en) Antiinflammatory, immunosuppressive and antialleric 16, 17-alkylidioxy-steroids
PT92722A (pt) Processo de preparacao de esteroides substituidos com acido fosfonico e de composicoes farmaceuticas que os contem
AU2002210768A1 (en) Selective glucocorticoid receptor agonists
Hillisch et al. The significance of the 20-carbonyl group of progesterone in steroid receptor binding: a molecular dynamics and structure-based ligand design study
PT898579E (pt) Derivados de pregnano sem substituinte na posicao 17alfa sua utilizacao como medicamento processo para a sua preparacao intermediarios do processo e composicoes que os contem
EA027831B1 (ru) СПОСОБ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНЫХ СОСТОЯНИЙ С ПРИМЕНЕНИЕМ S-[4-(3-ФТОР-3-МЕТИЛБУТИРИЛОКСИ)БУТ-2-ИНИЛ]6α,9α-ДИФТОР-17α-(ФУРАН-2-ИЛ)КАРБОНИЛОКСИ-11β-ГИДРОКСИ-16α-МЕТИЛ-3-ОКСОАНДРОСТА-1,4-ДИЕН-17β-КАРБОТИОАТА
CA2653206A1 (en) Transporter-enhanced corticosteroid activity
Rasmusson et al. Therapeutic control of androgen action
Ali et al. Discovery of betamethasone 17α-carbamates as dissociated glucocorticoid receptor modulators in the rat
Kalvoda et al. Concept and development of a potent topical corticosteroid
Kohn Novel Allosteric Communication in Nuclear Receptor Activation